IKJ Capital

IKJ Capital is a Sao Paulo-based venture firm operating in one of Latin America’s most active healthcare technology markets. Brazil’s healthcare environment, with its mix of public and private systems, large patient populations, and fragmented service delivery, creates a distinctive context for digital health, AI, and biotech companies, and IKJ has positioned itself to engage with founders building inside that environment.

The healthcare focus runs through digital health, AI/ML in healthcare, and biotech. Within that, the firm tends to favor companies whose products address Brazilian healthcare problems with solutions that combine local market understanding, technical depth, and credible paths to scale. AI is treated as an embedded capability across the portfolio, and the firm is interested in companies whose machine learning work creates real advantages inside the operational and regulatory realities of Brazilian healthcare.

Check sizes run from $1M to $5M across pre-seed, seed, and Series A rounds. That positioning makes IKJ a natural early institutional participant for Brazilian healthcare technology companies, often as a lead or co-lead in formation rounds and as a meaningful participant in follow-on rounds. Founders should expect diligence focused on founder quality, problem framing inside the Brazilian context, early product signals, and the credibility of plans for scaling across Brazilian regions and, where applicable, into other Latin American markets.

The team brings investing and operating backgrounds, with relationships across Brazilian healthcare systems, payors, providers, and follow-on capital sources. Those networks are a meaningful part of what the firm offers portfolio companies, particularly for those whose progression depends on partnerships with Brazilian hospital groups, insurers, or pharmaceutical companies. The firm is comfortable working with first-time founders and is candid about the operational realities of building healthcare companies in a market where regulation, reimbursement, and infrastructure all present distinct challenges.

For founders, working with IKJ means an investor that is engaged on commercial strategy inside Brazil, follow-on fundraising, and the practical mechanics of scaling healthcare technology in a complex market. Post-investment support tends to focus on commercial introductions, hiring, follow-on syndication with both Latin American and international co-investors, and helping companies navigate the regulatory and reimbursement realities of Brazilian healthcare. The firm is a less natural fit for companies whose primary market is the US or Europe and whose Brazilian operations are incidental. It is a strong fit for healthcare and digital health teams building primarily for the Brazilian market who want an investor with deep local relationships and the operational understanding to support a multi-year path from early product validation through regional scaling. IKJ’s tone with founders tends to be commercially focused and grounded in local realities.